# The Vertical Group

> The Vertical Group is a VC fund backing Health Care and Medical Device. See 70 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Basking Ridge, United States
- Total investments: 70
- Last investment: Apr 2026
- Lead investor: 11%
- Fund size: $10M
- Last fund: Jan 2006
- Last updated: Aug 2026
- LinkedIn: http://www.linkedin.com/company/the-vertical-group
- Website: http://www.vertical-group.com

The Vertical Group is a New Jersey-based venture capital firm focused on the fields of medical technology and biotechnology.

## Contacts

5 contacts available for The Vertical Group. Shizune tracks 4 team members at The Vertical Group. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/the-vertical-group?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Series B | $5M–$60M |
| Series C | $1.5M–$77M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 28 | 40% |
| Medical Device | 18 | 26% |
| Medical | 16 | 23% |
| Biotechnology | 15 | 21% |
| Therapeutics | 6 | 9% |

29 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 15 | 21% |
| Series C | 11 | 16% |
| Funding Round | 10 | 14% |
| Series A | 9 | 13% |
| Series D | 5 | 7% |

11 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 33 | 47% |
| Israel | 1 | 1% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Jack W. Lasersohn | General Partner | 12 | https://shizune.co/investors/profile/jack-w-lasersohn |
| John E. Runnells | General Partner | 0 | https://shizune.co/investors/profile/john-e-runnells |
| Richard B. Emmitt | Founder/Managing Director | 2 | https://shizune.co/investors/profile/richard-b-emmitt |
| Tony Chou | General Partner | 2 | https://shizune.co/investors/profile/tony-m-chou |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Route 92 Medical | Route 92 Medical is a developer of a stealthy catheter for stroke treatment. The company was founded in 2015 and based in San Mateo, California. | $50M | Private Equity | Apr 07, 2026 |  |
| Mobia Medical | MicroTransponder is a medical device company that develops and commercializes neurostimulation devices to treat neurological diseases. Its therapies include paired vagus nerve stimulation system (Paired VNS System) and wireless neurostimulation system for the treatment of chronic pain, post-stroke upper limb mobility issues, and variousneurological indications that enable healthcare practitioners to treat post-stroke upper limb mobility issues.Founded in 2007, MicroTransponder is headquartered in Dallas, Texas. | $65M | Series F | Mar 12, 2025 |  |
| Route 92 Medical | Route 92 Medical is a developer of a stealthy catheter for stroke treatment. The company was founded in 2015 and based in San Mateo, California. | $50M | Series F | Sep 23, 2024 |  |
| Route 92 Medical | Route 92 Medical is a developer of a stealthy catheter for stroke treatment. The company was founded in 2015 and based in San Mateo, California. | $31M | Series F | Nov 16, 2023 |  |
| Luminopia | Luminopia develops a new class of treatments for significant neuro-visual disorders. The company is committed to creating digital therapeutics that are both rigorously evaluated for FDA approval and genuinely engaging for patients. As an Innovation Partner of Boston Children’s Hospital, the company is developing its lead product, Luminopia One, totreat amblyopia, the cause of vision loss among children. | $16M | Series A | Jun 27, 2023 |  |
| Luminopia | Luminopia develops a new class of treatments for significant neuro-visual disorders. The company is committed to creating digital therapeutics that are both rigorously evaluated for FDA approval and genuinely engaging for patients. As an Innovation Partner of Boston Children’s Hospital, the company is developing its lead product, Luminopia One, totreat amblyopia, the cause of vision loss among children. | $5.7M | Seed | Oct 19, 2022 |  |
| Mobia Medical | MicroTransponder is a medical device company that develops and commercializes neurostimulation devices to treat neurological diseases. Its therapies include paired vagus nerve stimulation system (Paired VNS System) and wireless neurostimulation system for the treatment of chronic pain, post-stroke upper limb mobility issues, and variousneurological indications that enable healthcare practitioners to treat post-stroke upper limb mobility issues.Founded in 2007, MicroTransponder is headquartered in Dallas, Texas. | $73M | Series E | Jun 20, 2022 |  |
| Carlsmed | Provider of medical technology for spine surgery. The company’s proprietary aprevo™ digital-to-device 3-D printed implant system for spine is first-ever surgical implant to be designated by the FDA as a breakthrough technology. Hospital and surgeon customers across the country choose aprevo™ for the benefits of personalized medicine in lumbarfusion surgery.Carlsmed was founded in 2018 and is headquartered in San Diego, California. | $30M | Series B | Apr 19, 2022 |  |
| Route 92 Medical | Route 92 Medical is a developer of a stealthy catheter for stroke treatment. The company was founded in 2015 and based in San Mateo, California. | $56M | Series E | Dec 14, 2021 |  |
| Carlsmed | Provider of medical technology for spine surgery. The company’s proprietary aprevo™ digital-to-device 3-D printed implant system for spine is first-ever surgical implant to be designated by the FDA as a breakthrough technology. Hospital and surgeon customers across the country choose aprevo™ for the benefits of personalized medicine in lumbarfusion surgery.Carlsmed was founded in 2018 and is headquartered in San Diego, California. | $10M | Series A | Dec 16, 2020 |  |

10 of 70 investments shown.

## Co-investors
- [U.S. Venture Partners](https://shizune.co/investors/profile/us-venture-partners) — VC Fund, 19 deals together
- [Latterell Venture Partners](https://shizune.co/investors/profile/latterell-venture-partners) — VC Fund, 12 deals together
- [Warburg Pincus](https://shizune.co/investors/profile/warburg-pincus) — VC Fund, 10 deals together
- [DeNovo Ventures](https://shizune.co/investors/profile/denovo-ventures) — VC Fund, 7 deals together
- [Morgenthaler Ventures](https://shizune.co/investors/profile/morgenthaler-ventures) — VC Fund, 5 deals together
- [Norwest](https://shizune.co/investors/profile/norwest-venture-partners) — VC Fund, 5 deals together

## Similar investors

### Similar industry
- [Innova Memphis](https://shizune.co/investors/profile/innova-memphis) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Enterprise Ireland](https://shizune.co/investors/profile/enterprise-ireland) — VC Fund

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

### Similar country
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## Featured in investor lists
- [Medical Device Investors in United States](https://shizune.co/investors/medical-device-investors-united-states)
- [Medical Device VC Funds in United States](https://shizune.co/investors/medical-device-vc-funds-united-states)

## FAQ

### What does The Vertical Group invest in?

The Vertical Group invests primarily in Health Care, Medical Device and Medical startups, most often at Series B and Series C stage. Most of the 70 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is The Vertical Group's check size?

The Vertical Group typically joins rounds of $5M–$60M at Series B and $1.5M–$77M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds The Vertical Group participates in.

### How do I contact The Vertical Group?

Public channels for The Vertical Group include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at The Vertical Group?

The team at The Vertical Group includes Jack W. Lasersohn (General Partner), John E. Runnells (General Partner) and Richard B. Emmitt (Founder/Managing Director). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co